Long term continence rates in patients undergoing augmentation cystoplasty with 30 year follow up
BAUS ePoster online library. Frost A. 06/21/21; 319089; p5-10
Disclosure(s): None
Anastasia Frost
REGULAR CONTENT
Login now to access Regular content available to all registered users.
Abstract
Discussion Forum (0)
Rate & Comment (0)
Introduction:
The aim of this study is to evaluate long term continence rate for patients up to 30 years after undergoing augmentation cystoplasty (AC) surgery.
Patients and Methods:
We retrospectively reviewed 183 patients (104 male, 79 female) with mean age at time of surgery of 23.6 years (3.7 – 73 years). They underwent AC between January 1981 and December 2009 by a single surgeon for a variety of benign bladder disorders. Median follow up was 17 years.
Results:
In 45 patients with an AC alone there is a continence rate of 90% at 1 year. 44% voiding spontaneously vs. 46% performing clean intermittent self-catheterisation (CISC). At 20 years 42% were dry with CISC, and 37% were able to void spontaneously giving a continence rate of 79%. 20.5% had an ileal conduit or Mitrofanoff. In 138 patients with an AUS, 80% had a working AUS at 1 year. 44% voided by straining and 36% performed CISC. In those who had the AUS removed 15% were dry with CISC and 1.6% had a Mitrofanoff. At 30 years 45% still maintained continence by way of an AUS (13% spontaneous voiding vs. 32% CISC), 13% were dry with CISC alone and 23% had a Mitrofanoff or ileal conduit.
Conclusion:
Patients undergoing AC alone can expect a continence rate of 79% at 20 years post op. Those with an AUS have a continence rate of 58% at 30 years. In all patients with AC there is 20% chance of needing a Mitrofanoff or ileal conduit.
The aim of this study is to evaluate long term continence rate for patients up to 30 years after undergoing augmentation cystoplasty (AC) surgery.
Patients and Methods:
We retrospectively reviewed 183 patients (104 male, 79 female) with mean age at time of surgery of 23.6 years (3.7 – 73 years). They underwent AC between January 1981 and December 2009 by a single surgeon for a variety of benign bladder disorders. Median follow up was 17 years.
Results:
In 45 patients with an AC alone there is a continence rate of 90% at 1 year. 44% voiding spontaneously vs. 46% performing clean intermittent self-catheterisation (CISC). At 20 years 42% were dry with CISC, and 37% were able to void spontaneously giving a continence rate of 79%. 20.5% had an ileal conduit or Mitrofanoff. In 138 patients with an AUS, 80% had a working AUS at 1 year. 44% voided by straining and 36% performed CISC. In those who had the AUS removed 15% were dry with CISC and 1.6% had a Mitrofanoff. At 30 years 45% still maintained continence by way of an AUS (13% spontaneous voiding vs. 32% CISC), 13% were dry with CISC alone and 23% had a Mitrofanoff or ileal conduit.
Conclusion:
Patients undergoing AC alone can expect a continence rate of 79% at 20 years post op. Those with an AUS have a continence rate of 58% at 30 years. In all patients with AC there is 20% chance of needing a Mitrofanoff or ileal conduit.
Introduction:
The aim of this study is to evaluate long term continence rate for patients up to 30 years after undergoing augmentation cystoplasty (AC) surgery.
Patients and Methods:
We retrospectively reviewed 183 patients (104 male, 79 female) with mean age at time of surgery of 23.6 years (3.7 – 73 years). They underwent AC between January 1981 and December 2009 by a single surgeon for a variety of benign bladder disorders. Median follow up was 17 years.
Results:
In 45 patients with an AC alone there is a continence rate of 90% at 1 year. 44% voiding spontaneously vs. 46% performing clean intermittent self-catheterisation (CISC). At 20 years 42% were dry with CISC, and 37% were able to void spontaneously giving a continence rate of 79%. 20.5% had an ileal conduit or Mitrofanoff. In 138 patients with an AUS, 80% had a working AUS at 1 year. 44% voided by straining and 36% performed CISC. In those who had the AUS removed 15% were dry with CISC and 1.6% had a Mitrofanoff. At 30 years 45% still maintained continence by way of an AUS (13% spontaneous voiding vs. 32% CISC), 13% were dry with CISC alone and 23% had a Mitrofanoff or ileal conduit.
Conclusion:
Patients undergoing AC alone can expect a continence rate of 79% at 20 years post op. Those with an AUS have a continence rate of 58% at 30 years. In all patients with AC there is 20% chance of needing a Mitrofanoff or ileal conduit.
The aim of this study is to evaluate long term continence rate for patients up to 30 years after undergoing augmentation cystoplasty (AC) surgery.
Patients and Methods:
We retrospectively reviewed 183 patients (104 male, 79 female) with mean age at time of surgery of 23.6 years (3.7 – 73 years). They underwent AC between January 1981 and December 2009 by a single surgeon for a variety of benign bladder disorders. Median follow up was 17 years.
Results:
In 45 patients with an AC alone there is a continence rate of 90% at 1 year. 44% voiding spontaneously vs. 46% performing clean intermittent self-catheterisation (CISC). At 20 years 42% were dry with CISC, and 37% were able to void spontaneously giving a continence rate of 79%. 20.5% had an ileal conduit or Mitrofanoff. In 138 patients with an AUS, 80% had a working AUS at 1 year. 44% voided by straining and 36% performed CISC. In those who had the AUS removed 15% were dry with CISC and 1.6% had a Mitrofanoff. At 30 years 45% still maintained continence by way of an AUS (13% spontaneous voiding vs. 32% CISC), 13% were dry with CISC alone and 23% had a Mitrofanoff or ileal conduit.
Conclusion:
Patients undergoing AC alone can expect a continence rate of 79% at 20 years post op. Those with an AUS have a continence rate of 58% at 30 years. In all patients with AC there is 20% chance of needing a Mitrofanoff or ileal conduit.
Code of conduct/disclaimer available in General Terms & Conditions
{{ help_message }}
{{filter}}